Jason Aryeh - 05 Jun 2026 Form 4 Insider Report for LIGAND PHARMACEUTICALS INC (LGND)

Reporting relationship: Director
Issuer ticker: LGND
Reported as of: 05 Jun 2026
Net transaction value: -$1,250,000
SEC form: 4
Accepted by SEC: 12 Jun 2026, 17:27:26 UTC
Prior SEC filing: 05 Jun 2026
Next SEC filing: 25 Jun 2026
Source filing: View source filing
Reporting owner signature: By: /s/ Andrew Reardon, Attorney-in-Fact For: Jason Aryeh

Key filing fact

Jason Aryeh filed Form 4 for LIGAND PHARMACEUTICALS INC (LGND) on 12 Jun 2026.

Key facts

This page summarizes Jason Aryeh's Form 4 filing for LIGAND PHARMACEUTICALS INC (LGND).
4 reported transactions and 1 derivative row are listed below.
Accepted by SEC: 12 Jun 2026, 17:27.

Change

Previous filing in this sequence was filed on 05 Jun 2026.
Current net transaction value: -$1,250,000.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001376960 Primary reporting owner

Aryeh Jason

Relationship: Director
Address: 555 HERITAGE DRIVE, SUITE 200, JUPITER
Signature: By: /s/ Andrew Reardon, Attorney-in-Fact For: Jason Aryeh
Signature date: 12 Jun 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

LGND transaction

Common Stock

Award

Transaction value
Shares: +836
Change %: +0.78%
Price: $0.000000^*
Shares after: 107,580
Date: 05 Jun 2026
Ownership: Direct
Footnotes: F1, F2

LGND transaction

Common Stock

Sale

Transaction value: $125,000
Shares: -500
Change %: -0.46%
Price: $250.00
Shares after: 107,080
Date: 10 Jun 2026
Ownership: Direct

LGND transaction

Common Stock

Sale

Transaction value: $1,125,000
Shares: -4,500
Change %: -4.2%
Price: $250.00
Shares after: 102,580
Date: 11 Jun 2026
Ownership: Direct

LGND holding

Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after: 13,000
Date: 05 Jun 2026
Ownership: Indirect
Footnotes: F3

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

LGND transaction Derivative

Non-Qualified Stock Option (right to buy)

Award

Transaction value
Shares: +2,938
Change %
Price: $0.000000^*
Shares after: 2,938
Date: 05 Jun 2026
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 2,938
Exercise price: $237.00
Footnotes: F4

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 4 footnotes

Footnote F1

Represents restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of the Issuer's common stock. Acquired by a grant of the Board of Directors of the Company at their annual meeting on June 5, 2026. Fully vests on the earlier of (A) the date of the next annual meeting of the Company stockholders following the grant date or (B) on the first anniversary of the date of grant.

Footnote F2

The total number of shares owned has been reduced by 7,825 shares to reflect a reallocation of the reporting person's shares in accordance with his account records.

Footnote F3

All securities disclosed in this Form 4 are owned by certain funds managed by JALAA Equities, LP, JLV Investments, LP and affiliates (the "Funds"). Jason Aryeh is the General Partner of JALAA Equities, LP and a partner of JLV Investments, LP. By reason of the provisions of Rule 16a-1 under the Securities Exchange Act of 1934, as amended, JALAA Equities, LP, JLV Investments, LP and affiliates and Mr. Aryeh may be deemed to be the beneficial owners of the securities beneficially owned by the Funds.

Footnote F4

Acquired by a grant of the Board of Directors of the Company at their annual meeting on June 5, 2026. Fully vests on the earlier of (A) the date of the next annual meeting of the Company stockholders following the grant date or (B) on the first anniversary of the date of grant.